Share:
Peer-Reviewed Publication
Cancer Epidemiol Biomarkers Prev2025;34(2):260-269.February 6, 2025Journal Article

Mammographic Density in Relation to Breast Cancer Risk Factors among Chinese Women.

Hela Koka1, Yuan Tian2, Lu Deng1, Kai Yu1, Er-Ni Li2, Changyuan Guo2, Jennifer L Guida1,3, Hyuna Sung4, Ariane Chan5,6, Nan Hu1, Ning Lu2, Gretchen L Gierach1, Jing Li2, Xiaohong R Yang1
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland.
2National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
3Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, DHHS, Bethesda, Maryland.
4Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia.
5Volpara Health Technologies Ltd, Wellington, New Zealand.
6Institute of Environmental Science and Research, Porirua, New Zealand.

Abstract

BACKGROUND: Increased mammographic density (MD) is a known breast cancer risk factor, but its influencing factors are unclear in Asian populations. This study examined the links between known breast cancer risk factors and quantitatively measured MD in 7,351 Chinese women with nonmalignant mammographic findings. METHODS: VolparaDensity software quantified volumetric MD measures: total breast volu…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.